Understanding the role of SOX9 in acquired diseases: Lessons from development

Trends in Molecular Medicine

Volumn 17, Issue 3, 2011, Pages 166-174

  Pritchett, James ^a   Athwal, Varinder ^a   Roberts, Neil ^a   Hanley, Neil A ^a   Hanley, Karen Piper ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR SOX9;

CAMPOMELIC DYSPLASIA; CARCINOGENESIS; CELL PROLIFERATION; CHONDROGENESIS; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROSIS; GENE MUTATION; HUMAN; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; SCLEROSIS; SIGNAL TRANSDUCTION; STEM CELL; TESTIS DEVELOPMENT;

ANIMALS; DISEASE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; SOX9 TRANSCRIPTION FACTOR;

EID: 79952455908     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2010.12.001     Document Type: Review

References (101)

1. Gordon C.T., et al. Long-range regulation at the SOX9 locus in development and disease. J. Med. Genet. 2009, 46:649-656.
2. Wagner T., et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994, 79:1111-1120.
3. Levay A.K., et al. Scleraxis is required for cell lineage differentiation and extracellular matrix remodeling during murine heart valve formation in vivo. Circ. Res. 2008, 103:948-956.
4. Piper Hanley K., et al. Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J. Biol. Chem. 2008, 283:14063-14071.
5. Bennett M.R., et al. Laser capture microdissection-microarray analysis of focal segmental glomerulosclerosis glomeruli. Nephron. Exp. Nephrol. 2007, 107:e30-40.
6. Naitoh M., et al. Gene expression in human keloids is altered from dermal to chondrocytic and osteogenic lineage. Genes Cells 2005, 10:1081-1091.
7. Sumi E., et al. SRY-related HMG box 9 regulates the expression of Col4a2 through transactivating its enhancer element in mesangial cells. Am. J. Pathol. 2007, 170:1854-1864.
8. Neven E., et al. Endochondral bone formation is involved in media calcification in rats and in men. Kidney Int. 2007, 72:574-581.
9. Thomsen M.K., et al. SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res. 2010, 70:979-987.
10. Sutter R., et al. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene 2010, 29:1845-1856.
11. Darido C., et al. Defective Claudin-7 regulation by Tcf-4 and Sox-9 disrupts the polarity and increases the tumorigenicity of colorectal cancer cells. Cancer Res. 2008, 68:4258-4268.
12. Wang H., et al. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res. 2008, 68:1625-1630.
13. Akiyama H. Control of chondrogenesis by the transcription factor Sox9. Mod. Rheumatol. 2008, 18:213-219.
14. Lefebvre V., et al. Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int. J. Biochem. Cell Biol. 2007, 39:2195-2214.
15. Liu C.J., et al. Transcriptional activation of cartilage oligomeric matrix protein by Sox9, Sox5, and Sox6 transcription factors and CBP/p300 coactivators. Front Biosci. 2007, 12:3899-3910.
16. Coustry F., et al. The dimerization domain of SOX9 is required for transcription activation of a chondrocyte-specific chromatin DNA template. Nucleic Acids Res. 2010, 38:6018-6028.
17. Bernard P., et al. Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum. Mol. Genet. 2003, 12:1755-1765.
18. Deschaseaux F., et al. Mechanisms of bone repair and regeneration. Trends Mol. Med. 2009, 15:417-429.
19. Barrionuevo F., Scherer G. SOX E genes: SOX9 and SOX8 in mammalian testis development. Int. J. Biochem. Cell Biol. 2010, 42:433-436.
20. Huang B., et al. Autosomal XX sex reversal caused by duplication of SOX9. Am. J. Med. Genet. 1999, 87:349-353.
21. Sekido, R. and Lovell-Badge, R. (2008) Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature (2008/05/06 edn), 930-934.
22. Sim H., et al. Boys, girls and shuttling of SRY and SOX9. Trends Endocrinol. Metab. 2008, 19:213-222.
23. Haldin C.E., LaBonne C. SoxE factors as multifunctional neural crest regulatory factors. Int. J. Biochem. Cell Biol. 2010, 42:441-444.
24. Stolt C.C., Wegner M. SoxE function in vertebrate nervous system development. Int. J. Biochem. Cell Biol. 2010, 42:437-440.
25. Scott C.E., et al. SOX9 induces and maintains neural stem cells. Nat. Neurosci. 2010, 13:1181-1189.
26. Betters E., et al. Analysis of early human neural crest development. Dev. Biol. 2010, 344:578-592.
27. Sakai D., et al. Cooperative action of Sox9, Snail2 and PKA signaling in early neural crest development. Development 2006, 133:1323-1333.
28. Cheung M., et al. The transcriptional control of trunk neural crest induction, survival, and delamination. Dev. Cell 2005, 8:179-192.
29. Bajpai R., et al. CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature 2010, 463:958-962.
30. Lee J.M., et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. Journal of Cell Biology 2006, 172:973-981.
31. Piper K, et al. Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia. Mech. Dev. 2002, 116:223-226.
32. Seymour P.A., et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1865-1870.
33. Lynn F.C., et al. Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10500-10505.
34. Mori-Akiyama Y., et al. SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology 2007, 133:539-546.
35. Formeister E.J., et al. Distinct SOX9 levels differentially mark stem/progenitor populations and enteroendocrine cells of the small intestine epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G1108-1118.
36. Blache P., et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J. Cell Biol. 2004, 166:37-47.
37. Akiyama H., et al. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6502-6507.
38. Lincoln J., et al. Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. Dev. Biol. 2007, 305:120-132.
39. Nowak J.A., et al. Hair follicle stem cells are specified and function in early skin morphogenesis. Cell Stem Cell 2008, 3:33-43.
40. Vidal V.P., et al. Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr. Biol. 2005, 15:1340-1351.
41. Barrionuevo F., et al. Sox9 is required for invagination of the otic placode in mice. Dev. Biol. 2008, 317:213-224.
42. Mitsiadis T.A., et al. Expression of the transcription factors Otlx2, Barx1 and Sox9 during mouse odontogenesis. Eur. J. Oral. Sci. 1998, 106(Suppl. 1):112-116.
43. Antoniou A., et al. Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. Gastroenterology 2009, 136:2325-2333.
44. Thomsen M.K., et al. The role of Sox9 in prostate development. Differentiation 2008, 76:728-735.
45. Fauquier T., et al. SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2907-2912.
46. Peacock J.D., et al. Reduced Sox9 function promotes heart valve calcification phenotypes in vivo. Circ. Res. 2010, 106:712-719.
47. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
48. Furuyama, K. et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat. Genet. (in press).
49. Airik, R. et al. Hydroureternephrosis due to loss of Sox9-regulated smooth muscle cell differentiation of the ureteric mesenchyme. Hum. Mol. Genet. (in press).
50. Schulick A.H., et al. Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6983-6988.
51. Aleman A., et al. Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays. Br. J. Cancer 2007, 98:466-473.
52. Kato N.M.D., et al. Expression of a transcription factor, SOX9, in sertoli-stromal cell tumors of the ovary. Int. J. Gynecol. Pathol. 2004, 23:180-181.
53. Malki S., et al. Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells. Cancer Lett. 2007, 255:182-193.
54. Schaeffer E.M., et al. Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene 2008, 27:7180-7191.
55. Wang H., et al. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Cancer Res. 2007, 67:528-536.
56. Lu B., et al. Analysis of SOX9 expression in colorectal cancer. Am. J. Clin. Pathol. 2008, 130:897-904.
57. Miller S.J., et al. Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol. Med. 2009, 1:236-248.
58. Thomsen M.K., et al. SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res. 2010, 70:979-987.
59. Drivdahl R., et al. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9. Oncogene 2004, 23:4584-4593.
60. Kordes U., Hagel C. Expression of SOX9 and SOX10 in central neuroepithelial tumor. J. Neurooncol. 2006, 80:151-155.
61. Swartling F.J., et al. Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene 2009, 28:3121-3131.
62. Ramocki N.M., et al. Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits apcmin/+ tumors, and regulates Sox9. Endocrinology 2008, 149:261-267.
63. Vidal V.P.I., et al. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms. J. Cutan. Pathol. 2008, 35:373-379.
64. Vidal V.P.I., et al. Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr. Biol. 2005, 15:1340-1351.
65. Passeron T., et al. Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J. Clin. Invest. 2009, 119:954-963.
66. Rao P., et al. Expression of Sox-9 in metastatic melanoma - a potential diagnostic pitfall. Am. J. Dermatopathol. 2010, 32:262-266.
67. Jiang S.S., et al. Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin. Cancer Res. 2010, 16:4363-4373.
68. Afonja O., et al. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition. Oncogene 2002, 21:7850-7860.
69. Muller P., et al. SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells. Breast Cancer Res. Treat. 2010, 120:317-326.
70. Sawyers C.L. The cancer biomarker problem. Nature 2008, 452:548-552.
71. Gressner O.A., et al. Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J. Cell Mol. Med. 2007, 11:1031-1051.
72. Kim S.S., et al. Strategies for targeted nonviral delivery of siRNAs in vivo. Trends Mol. Med. 2009, 15:491-500.
73. Enever C., et al. Next generation immunotherapeutics - honing the magic bullet. Curr. Opin. Biotechnol. 2009, 20:405-411.
74. Benko S., et al. Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat. Genet. 2009, 41:359-364.
75. Ushita M., et al. Transcriptional induction of SOX9 by NF-kappaB family member RelA in chondrogenic cells. Osteoarthritis Cartilage 2009, 17:1065-1075.
76. Piera-Velazquez S., et al. Regulation of the human SOX9 promoter by Sp1 and CREB. Exp. Cell Res. 2007, 313:1069-1079.
77. Tew S.R., Hardingham T.E. Regulation of SOX9 mRNA in human articular chondrocytes involving p38 MAPK activation and mRNA stabilization. J. Biol. Chem. 2006, 281:39471-39479.
78. Lu Y., et al. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol. 2007, 310:442-453.
79. Miyaki S., et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 2009, 60:2723-2730.
80. Cheng L.C., et al. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 2009, 12:399-408.
81. Khraiwesh B., et al. Transcriptional control of gene expression by microRNAs. Cell 2010, 140:111-122.
82. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 2009, 119:1417-1419.
83. Thiery J.P., et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
84. Monsoro-Burq A.H., et al. Neural crest induction by paraxial mesoderm in Xenopus embryos requires FGF signals. Development 2003, 130:3111-3124.
85. Lee Y.H., et al. Early requirement of the transcriptional activator Sox9 for neural crest specification in Xenopus. Dev. Biol. 2004, 275:93-103.
86. Guemar L., et al. The small GTPase RhoV is an essential regulator of neural crest induction in Xenopus. Dev. Biol. 2007, 310:113-128.
87. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
88. Bowen K.A., et al. PTEN loss induces epithelial-mesenchymal transition in human colon cancer cells. Anticancer Res. 2009, 29:4439-4449.
89. Endo Y., et al. Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells. PLoS ONE 2008, 3:e2714.
90. Akiyama H., et al. Interactions between Sox9 and β-catenin control chondrocyte differentiation. Genes Dev. 2004, 18:1072-1087.
91. Topol L., et al. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J. Biol. Chem. 2008.
92. Montero J.A., et al. Activin/TGFbeta and BMP crosstalk determines digit chondrogenesis. Dev. Biol. 2008, 321:343-356.
93. Park J., et al. Regulation of Sox9 by Sonic Hedgehog (Shh) is essential for patterning and formation of tracheal cartilage. Dev. Dyn. 2010, 239:514-526.
94. Grogan S.P., et al. Repression of chondrogenesis through binding of notch signaling proteins HES-1 and HEY-1 to N-box domains in the COL2A1 enhancer site. Arthritis Rheum. 2008, 58:2754-2763.
95. Murakami S., et al. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:1113-1118.
96. Acevedo V.D., et al. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell 2007, 12:559-571.
97. Finzsch M., et al. Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression. Development 2008, 135:637-646.
98. Muto A., et al. The group E Sox genes Sox8 and Sox9 are regulated by Notch signaling and are required for Muller glial cell development in mouse retina. Exp. Eye Res. 2009, 89:549-558.
99. Esain V., et al. FGF-receptor signalling controls neural cell diversity in the zebrafish hindbrain by regulating olig2 and sox9. Development 2010, 137:33-42.
100. Müller P., et al. SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells. Breast Cancer Research and Treatment 2009.
101. Mead T.J., Yutzey K.E. Notch pathway regulation of chondrocyte differentiation and proliferation during appendicular and axial skeleton development. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14420-14425.